Web Results

supreme.justia.com/cases/federal/us/562/223

Feb 22, 2011 ... SYLLABUS OCTOBER TERM, 2010. BRUESEWITZ V. WYETH LLC SUPREME COURT OF THE UNITED STATES. BRUESEWITZ et al. v. WYETH LLC, fka WYETH, INC., et al. certiorari to the united states court of appeals for the third circuit. No. 09–152. Argued October 12, 2010—Decided February 22, ...

www.americanbar.org/newsletter/publications/aba_health_esource_home/aba_health_law_esource_1104_brown.html

Bruesewitz v. Wyeth's Impact on the Vaccine Safety Debate. By Erin C. Fuse Brown1 & Jalayne J. Arias2, Public Health Law and Policy Program at Sandra Day ... The United States Supreme Court ruled that NCVIA preemptively bars all state-law design-defect claims against vaccine manufacturers.10 Justice Scalia, writing ...

healthland.time.com/2011/02/24/bruesewitz-v-wyeth-what-the-supreme-court-decision-means-for-vaccines

Feb 24, 2011 ... Vaccine injury is a tricky thing to prove — medically and legally. So it was inevitably controversial when the Supreme Court ruled on Tuesday against the parents of Hannah Bruesewitz, 18, who suffered seizures and permanent brain damage after receiving a diptheria-tetanus-pertussis (DTP) vaccine i...

www.aei.org/publication/west-virginia-supreme-court-strikes-down-learned-intermediary-rule

Nov 15, 2007 ... [2] Perez v. Wyeth Laboratories, Inc. was not followed in other jurisdictions until 2007,[3] when the West Virginia Supreme Court used the rationalization of direct- to-consumer advertising in State ex rel. Johnson & Johnson Corp. v. Karl (a case where there was none at issue) to hold that it would be the first ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4851267

Oct 27, 2015 ... Some of these side effects may cause symptoms similar to those of schizophrenia , such as secondary negative symptoms (Bernardo et al., 2013), while some subjects may develop side effects .... The rates of antipsychotic polytherapy in the nonaffective vs affective diagnosis groups were almost identical.

www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)62123-1/fulltext

May 20, 2015 ... Second, all the parameters that need regular assessment, such as thyroid and renal function tests and plasma lithium and calcium concentrations, can .... Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.

www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61828-6/fulltext

Dec 23, 2009 ... Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. The BALANCE ... All outcome events were considered by the trial management team, who were masked to treatment assignment. Participants were ...

trklaw.com/wp-content/uploads/higbridge-decision_20141124_ALS.pdf

Nov 24, 2014 ... v. ASSESSOR OF THE TOWN OF. NISKAYUNA et al.,. MEMORANDUM AND ORDER. Respondent, and. SOUTH COLONIE CENTRAL SCHOOL. DISTRICT ... petitioner's failure to comply" (Matter of Wyeth Holdings. Corp. v ... Mohawk Power Corp. v Assessor of Town of Geddes, 92 NY2d 192, 196. [1998]).

ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.161.9.1537

Sep 1, 2004 ... However, the available evidence favoring lithium, for example, would not be sufficient to register it as an antidepressant in the current regulatory climate because there are no trials showing superiority versus placebo or an active comparator that meets current standards of trial design. Almost all were small ...